ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,315.60
0.44%
Dow Jones
38,386.09
0.38%
Brent Oil
87.095
-0.22%
Bitcoin
63,799.98
-0.06%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Sanofi (SAN) Quote

Sanofi

Sanofi (SAN)

Sagalio Energy Ltd
Sant Uk.10te%
Banco Santander SA
91.84
0.61
(0.67%)
Closed April 29 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
91.84
Bid
91.63
Ask
91.90
Volume
1,273,910
91.64 Day's Range 92.67
80.60 52 Week Range 104.32
Market Cap
116.16B
Previous Close
91.23
Open
91.66
Last Trade
7061
@
91.84
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,375,345
Shares Outstanding
1,264,803,301
Dividend Yield
7.75%
PE Ratio
21.51
Earnings Per Share (EPS)
4.27
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
www.sanofi.com
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 91.23 €. Over the last year, Sanofi shares have traded in a share price range of 80.60 € to 104.32 €.

Sanofi currently has 1,264,803,301 shares outstanding. The market capitalization of Sanofi is 116.16 € billion. Sanofi has a price to earnings ratio (PE ratio) of 21.51.

SAN Latest News

More News

Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements

Communiqué de presse : Sanofi réitère ses objectifs financiers pour 2024, après une forte croissance de 7% portée par les lancements                                                         ...

April 25 2024
GlobeNewswire Inc.

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris...

April 25 2024
GlobeNewswire Inc.

Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential of...

April 23 2024
GlobeNewswire Inc.

Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en plaques

Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en...

April 17 2024
GlobeNewswire Inc.

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a potential first-in-class, high-efficacy, non-lymphocyte...

April 17 2024
GlobeNewswire Inc.

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8...

April 12 2024
GlobeNewswire Inc.

Sanofi: Information concerning the total number of voting rights and shares - March 2024

Sanofi: Information concerning the total number of voting rights and shares - March 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

April 12 2024
GlobeNewswire Inc.

Sanofi - AGM 30.04.2024 - Mise à disposition des documents préparatoires

Sanofi - AGM 30.04.2024 - Mise à disposition des documents préparatoires ASSEMBLEE GENERALE MIXTE DU 30 AVRIL 2024 MODALITES DE MISE A DISPOSITION OU DE CONSULTATION DES DOCUMENTS...

April 08 2024
GlobeNewswire Inc.

Sanofi - AGM 30.04.2024 - Availability of Preparatory documents

Sanofi - AGM 30.04.2024 - Availability of Preparatory documents COMBINED GENERAL MEETING OF APRIL 30, 2024 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to...

April 08 2024
GlobeNewswire Inc.

Press Release: Availability of the Q1 2024 Memorandum for modelling purposes

Availability of the Q1 2024 Memorandum for modelling purposes Paris, France – March 22, 2024. Sanofi announced today that its Q1 2024 Memorandum for modelling purposes is available on the...

March 22 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.354.9719967996387.4992.6786.74183082290.00352833DE
42.472.7637909813189.3792.6785.07146734488.12888067DE
124.45.0320219579187.4492.6784.93137534588.02215718DE
2610.3412.687116564481.596.581.18148055288.20208005DE
52-5.76-5.9016393442697.6104.3280.6144279592.92043552DE
1563.083.4700315457488.76106.6676.45180003491.15159988DE
26014.919.365739537376.94106.6667.65205369487.30459327DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSLRComplete Solaria Inc
$ 0.7303
(91.73%)
25.8M
MULNMullen Automotive Inc
$ 5.73
(81.33%)
72.12M
DCPHDeciphera Pharmaceuticals Inc
$ 25.28
(72.56%)
50.72M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
LICNLichen China Limited
$ 2.03
(48.18%)
3.96M
CLVRClever Leaves Holdings Inc
$ 1.62
(-60.58%)
768.37k
ADXNAddex Therapeutics Ltd
$ 7.68
(-52.30%)
160.84k
TSDDGraniteShares ETF Trust GraniteShares
$ 17.1879
(-30.97%)
1.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 27.23
(-30.66%)
7.72M
MFImF International Ltd
$ 1.665
(-28.54%)
3.55M
TSLATesla Inc
$ 194.05
(15.31%)
243.77M
SINTSiNtx Technologies Inc
$ 0.053477
(32.37%)
174.36M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
SOFISoFi Technologies Inc
$ 7.045
(-10.48%)
149.62M
SQQQProShares UltraPro Short QQQ
$ 11.31
(-1.05%)
97.67M

Discussion

View Full Feed
alidare alidare 4 minutes ago
Don’t take anything too seriously on anonymous public boards. Do your own DD and use these boards for entertainment only. Watch for them stock tips on public boards. Always an agendas on both sides.

My buddy took a job circumcising elephants at the zoo.

The money's not
AABB
DrivenByPain DrivenByPain 4 minutes ago
How About Now Dr 🤡
ECGI
georgejjl georgejjl 5 minutes ago
"... The most common adverse events with KarXT versus placebo were constipation (27 [21%] vs 13 [10%]), dyspepsia (24 [19%] vs 10 [8%]), headache (17 [14%] vs 15 [12%]), nausea (24 [19%] vs seven [6%]), vomiting (18 [14%] vs one [1%]), hypertension (12 [10%] vs one [1%]), dizziness (11 [9%] vs four
AVXL
Zardiw Zardiw 5 minutes ago
A huge wave of new small business loans will be serviced by $IDGR Oxygen Commercial:

According to a survey by the Exit Planning Institute, over 70% of business owners aged 50 or older planned to exit their businesses within the next ten years.

https://www.otcmarkets.co
IDGR
georgebailey georgebailey 5 minutes ago
What’s an NEO ?
NWBO
Roofus Roofus 5 minutes ago
All good
RDGL
Silverado1669 Silverado1669 5 minutes ago
They are the only source at this point. They know what they are doing. They shouldn’t post about anything as it can be inferred as misleading investors.
CNNA
Zardiw Zardiw 5 minutes ago
A huge wave of new small business loans will be serviced by $IDGR Oxygen Commercial:

According to a survey by the Exit Planning Institute, over 70% of business owners aged 50 or older planned to exit their businesses within the next ten years.

https://www.otcmarkets.co
IDGR
ShortyBusted ShortyBusted 5 minutes ago
The FINRA data posted tonight was the daily short volume and reflected as a % of the daily trade. Chomp Chomp

"The short interest data is just a snapshot that reflects short positions held by brokerage firms at a specific moment in time on two discrete days each month. The Short Sale
SPZI
HoldEm777 HoldEm777 6 minutes ago
Can’t really trade the trade with this liquidity… but I do follow what your saying.
https://investorshub.advfn.com/uimage/uploads/2024/4/29/dpsoz14F9745D-E97E-40F6-AD74-EA721B7FE8B4.png
IVRN
rosemountbomber rosemountbomber 6 minutes ago
Thanks for the link Kiwi.
UNCY
shotsky shotsky 6 minutes ago
Thank you. People that look things up learn. Those that guess never do but they claim they do.
SPZI
KILLAZILLA KILLAZILLA 6 minutes ago
EAGLE EYE ALERT FROM A PUMPING FOOL!!!

~NOTHING BUT A POS SCAM RUN BY LYING GRIFTERS!!!

~NONE REPORTING GARBAGE!!!!

~FINS MUST BE REALLY BAD!!!!
WDLF
FFFacts FFFacts 6 minutes ago
Tulsi has a greater than 50% chance of being VP.
FNMA
RANGOLEGEND RANGOLEGEND 7 minutes ago
NPHC Gave them a $250,000 cash loan. I don’t know what the interest rate was, but stemstation couldn’t pay them back so they gave them 100 million shares in return after a lawsuit.

Shocking, huh? NPHC had $250,000 cash?
NPHC
OMOLIVES OMOLIVES 8 minutes ago
Smart move. That's only a 5000 capacity venue...but it's clean. That is also the only team that Humbl sells tickets for. I heard the reporter state $20-$40 range...and if kids are free, that will fill seats(presentation). I would actually love to see something like this in small venues for small
HMBL
ChannelTrader ChannelTrader 8 minutes ago
$BLEG Chart 04/29/2024

https://pbs.twimg.com/media/GMYSVwaXUAApRWT?format=png&name=900x900
BLEG
loophole lawyer loophole lawyer 8 minutes ago
$VPLM new insider selling: 333168 shares. insiderbuyingselling.com/?t..
VPLM
MrMike241 MrMike241 9 minutes ago
I finally caught up on this chatty message board! I've been behind for months. Work, work, work... At one point I had almost 900 unread messages. There was lots of good drooling, I mean reading, around the holidays, from the usual suspects 😋
KILLAZILLA KILLAZILLA 10 minutes ago
7 total trades. ZERO buy volume...

THIS SCAM IS OVER!!!!!!!!!!

EAGLE EYE ALERT!!!!!!!!

STICK A FORK IN IT!!!!!!!

TOLD ALL you FOOLS!!!!!
INQD
SonicHaven6 SonicHaven6 10 minutes ago
Gilead’s share price once upon a time was 16 cents, if someone or a company tried to buy 50 percent of cydy’s stock to control the company, the share price would exponentially go too high to achieve or longs would reach their personal exit point anyway, The drug works and Dr Jay will get it over th
CYDY
loophole lawyer loophole lawyer 10 minutes ago
insiderbuyingselling
5:09 PM
$VPLM new insider selling: 498890 shares. insiderbuyingselling.com/?t..
VPLM
HoldEm777 HoldEm777 10 minutes ago
I still think it’s related to the unsolicited quotes only designation but I could be wrong. It’s like it was a expert market ticker without the label.

Quotes in the Expert Market will be “Unsolicited Only.” This means broker-dealers may use the Expert Market to meet their Best Execut
IVRN
OrbitAlchemist95 OrbitAlchemist95 10 minutes ago
He should stop making such ridiculous statements. It's kills his credibility. I used to be a fan.. Still heavily invested in AABB but he makes it hard to continue to like him with this stuff.
AABB
blackhawks blackhawks 10 minutes ago
Image Dump 4/29/24

https://www.democraticunderground.com/100218878622

https://i.postimg.cc/3xKdNqcr/98.jpg

https://i.postimg.cc/hj8kX2wg/0.jpg

https://i.postimg.cc/1zGCBfKr/40.jpg

https://i.postimg.cc/TPMNnrnP/41.jpg

Your Recent History

EU
SAN
Sanofi
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved